GenSci Seeking To Stay Injunction Of DynaGraft Gel, Putty Products
This article was originally published in The Gray Sheet
Executive Summary
GenSci is planning to appeal a Los Angeles jury's $14.5 mil. damage award to Osteotech for patent infringement through the sale of its DynaGraft Gel and Putty bone products